Curated news and analysis on clinical trials, drug approvals, and medical research.
Zimbabwe rolled out lenacapavir, a twice-yearly HIV prevention injection, on Thursday for high-risk populations including sex workers and adolescent girls. The donor-supported program will initially reach 46,000 people across 24 sites.
Bristol Myers Squibb faces a steep patent cliff with key drugs losing protection between 2027-2029, but newer products like Cobenfy show promise. The stock trades at less than 10 times earnings with a 4.2% dividend yield.
The Kentucky Office of Homeland Security has issued a warning after detecting Cychlorphine, a synthetic drug ten times stronger than fentanyl, in central Kentucky. The drug is contributing to overdose deaths in neighboring regions including East Tennessee.
